Global Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market Size, Share, Growth Analysis, By End User (Hospitals, Diagnostic Centers), By Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), By Test Type (Antinuclear Antibody Tests, Urinalysis), By Region -Industry Forecast 2026-2033

Report ID: SQMIG35D2178 | Region: Global | Published Date: October, 2024
Pages: 157 |Tables: 59 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Autoimmune Disease Diagnostics Market size was valued at USD 4.75 Billion in 2024 and is poised to grow from USD 4.95 Billion in 2025 to USD 6.85 Billion by 2033, growing at a CAGR of 4.15% during the forecast period (2026–2033).

    nvesting in generating more awareness regarding autoimmune diseases is also expected to be a key strategy in the future. Developing advanced and easy to use diagnostic tests is projected to be the prime focus of all autoimmune disease diagnostics companies going forward. Targeting countries with high geriatric population is estimated to create new business scope for all market players in the long run.    'Abbott Laboratories ', 'Thermo Fisher Scientific Inc. ', 'Siemens AG ', 'F. Hoffmann-La Roche Ltd ', 'Bio-Rad Laboratories, Inc. ', 'Quest Diagnostics Incorporated ', 'Hologic, Inc. ', 'Danaher Corporation ', 'Inova Diagnostics, Inc. ', 'PerkinElmer Germany Diagnostics GmbH ', 'Grifols, S.A. ', 'Bio-Techne Corporation ', 'Menarini Group ', 'Myriad Genetics, Inc. ', 'Medac GmbH ', 'ImmunArray ', 'Exagen Inc. ', 'ORGENTEC Diagnostika GmbH ', 'Seramun Diagnostica GmbH ', 'SQI Diagnostics Inc.'

    Use of AI for Diagnostics: Autoimmune disease diagnostics companies can focus on integrating artificial intelligence technology to analyze large datasets of results to find patterns and improve the diagnostic and treatment outcomes for patients in the future. Use of artificial intelligence can also help autoimmune disease diagnostics providers enhance their scope of automation in the long run.  

    North America is predicted to spearhead the demand for autoimmune disease diagnostics in the world. The presence of a strong healthcare ecosystem, high investments in the development of advanced diagnostic technologies, and availability of favorable reimbursement policies are forecasted to bolster the dominance of this region. Rising adoption of telehealth practices are also estimated to uplift the demand for autoimmune disease diagnostics in North America. Canada and the United States are expected to be the most opportune markets for autoimmune disease diagnostics providers operating in this region through 2031.  

    Related Reports

    Immunodiagnostics Market
    Buy Now GET FREE SAMPLE
    Infectious Disease Diagnostics Market
    Buy Now GET FREE SAMPLE
    Immunoprotein Diagnostic Testing Market
    Buy Now GET FREE SAMPLE
    Allergy Diagnostics Market
    Buy Now GET FREE SAMPLE
    Immunohematology Market
    Buy Now GET FREE SAMPLE
    Veterinary Immunodiagnostics Market
    Buy Now GET FREE SAMPLE
    Rapid Diagnostics Market
    Buy Now GET FREE SAMPLE
    Molecular Diagnostics Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Autoimmune Disease Diagnostics Market

    Report ID: SQMIG35D2178

    $5,300
    BUY NOW